Viking Therapeutics, Inc. - COMMON STOCK (VKTX)

Q3 2019 13F Holders as of 9/30/2019

Type / Class
Equity / COMMON STOCK
Shares outstanding
112M
Number of holders
136
Total 13F shares, excl. options
40.5M
Shares change
-4.42M
Total reported value, excl. options
$279M
Value change
-$33.6M
Put/Call ratio
0.37
Number of buys
55
Number of sells
-64
Price
$6.88

Significant Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q3 2019

176 filings reported holding VKTX - Viking Therapeutics, Inc. - COMMON STOCK as of Q3 2019.
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) has 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 40.5M shares of 112M outstanding shares and own 36.06% of the company stock.
Largest 10 shareholders include ArrowMark Colorado Holdings LLC (8.13M shares), BlackRock Inc. (4.5M shares), STATE STREET CORP (3.86M shares), VANGUARD GROUP INC (3.14M shares), FMR LLC (2.95M shares), Park West Asset Management LLC (1.75M shares), FIERA CAPITAL CORP (1.31M shares), NORTHERN TRUST CORP (829K shares), GEODE CAPITAL MANAGEMENT, LLC (788K shares), and Sio Capital Management, LLC (755K shares).
This table shows the top 136 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.